» Articles » PMID: 36352846

Telomere Length and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The causal direction and magnitude of the associations between telomere length (TL) and cardiovascular diseases (CVDs) remain uncertain due to susceptibility of reverse causation and confounding. This study aimed to investigate the associations between TL and CVDs using Mendelian randomization (MR).

Materials And Methods: In this two-sample MR study, we identified 154 independent TL-associated genetic variants from a genome-wide association study (GWAS) consisting of 472,174 individuals (aged 40-69) in the UK Biobank. Summary level data of CVDs were obtained from different GWASs datasets. Methods of inverse variance weighted (IVW), Mendelian Randomization-Egger (MR-Egger), Mendelian Randomization robust adjusted profile score (MR-RAPS), maximum likelihood estimation, weighted mode, penalized weighted mode methods, and Mendelian randomization pleiotropy residual sum and outlier test (MR-PRESSO) were conducted to investigate the associations between TL and CVDs.

Results: Our findings indicated that longer TL was significantly associated with decreased risk of coronary atherosclerosis [odds ratio (OR), 0.85; 95% confidence interval (CI), 0.75-0.95; = 4.36E-03], myocardial infarction (OR, 0.72; 95% CI, 0.63-0.83; = 2.31E-06), ischemic heart disease (OR, 0.87; 95% CI, 0.78-0.97; = 1.01E-02), stroke (OR, 0.87; 95% CI, 0.79-0.95; = 1.60E-03), but an increased risk of hypertension (OR, 1.12; 95% CI, 1.02-1.23; = 2.00E-02). However, there was no significant association between TL and heart failure (OR, 0.94; 95% CI, 0.87-1.01; = 1.10E-01), atrial fibrillation (OR, 1.01; 95% CI, 0.93-1.11; = 7.50E-01), or cardiac death (OR, 0.95; 95% CI, 0.82-1.10; = 4.80E-01). Both raw and outlier corrected estimates from MR-PRESSO were consistent with those of IVW results. The sensitivity analyses showed no evidence of pleiotropy (MR-Egger intercept, > 0.05), while Cochran's test and MR-Egger suggested different degrees of heterogeneity.

Conclusion: Our MR study suggested that longer telomeres were associated with decreased risk of several CVDs, including coronary atherosclerosis, myocardial infarction, ischemic heart disease, and stroke, as well as an increased risk of hypertension. Future studies are still warranted to validate the results and investigate the mechanisms underlying these associations.

Citing Articles

The relationship between telomere length and aging-related diseases.

Huang X, Huang L, Lu J, Cheng L, Wu D, Li L Clin Exp Med. 2025; 25(1):72.

PMID: 40044947 PMC: 11882723. DOI: 10.1007/s10238-025-01608-z.


Causal relationship between immune cells and heart failure: A Mendelian randomization study.

Lu S, Yu Y, Zhu Z, Wang M, Liu R, Liu J Medicine (Baltimore). 2025; 104(2):e41247.

PMID: 39792752 PMC: 11730111. DOI: 10.1097/MD.0000000000041247.


Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway.

Sung J, Kim S, Park S, Kim J, Choi H Exp Mol Med. 2024; 56(9):1967-1979.

PMID: 39223261 PMC: 11446938. DOI: 10.1038/s12276-024-01297-w.


Micronutrient intake and telomere length: findings from the UK Biobank.

Spinou M, Naska A, Nelson C, Codd V, Samani N, Bountziouka V Eur J Nutr. 2024; 63(8):2871-2883.

PMID: 39174689 DOI: 10.1007/s00394-024-03460-5.


Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study.

Ruan Y, Zhang P, Li X, Jia X, Yao D J Diabetes Investig. 2024; 15(11):1626-1636.

PMID: 39135422 PMC: 11527803. DOI: 10.1111/jdi.14273.


References
1.
Zgheib N, Sleiman F, Nasreddine L, Nasrallah M, Nakhoul N, Ismaeel H . Short Telomere Length is Associated with Aging, Central Obesity, Poor Sleep and Hypertension in Lebanese Individuals. Aging Dis. 2018; 9(1):77-89. PMC: 5772860. DOI: 10.14336/AD.2017.0310. View

2.
Richmond R, Davey Smith G . Mendelian Randomization: Concepts and Scope. Cold Spring Harb Perspect Med. 2021; 12(1). PMC: 8725623. DOI: 10.1101/cshperspect.a040501. View

3.
Zheng Y, Zhang N, Wang Y, Wang F, Li G, Tse G . Association between leucocyte telomere length and the risk of atrial fibrillation: An updated systematic review and meta-analysis. Ageing Res Rev. 2022; 81:101707. DOI: 10.1016/j.arr.2022.101707. View

4.
Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

5.
Nielsen J, Thorolfsdottir R, Fritsche L, Zhou W, Skov M, Graham S . Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018; 50(9):1234-1239. PMC: 6530775. DOI: 10.1038/s41588-018-0171-3. View